Chaturvedi Vivek, Basham Ryan P, Rezaei Kourous A
Department of Ophthalmology, Rush University Medical Center, Chicago; Illinois Retina Associates, Harvey, Illinois, USA.
Indian J Ophthalmol. 2014 Jul;62(7):804-8. doi: 10.4103/0301-4738.138621.
Purpose : To review the characteristics and outcomes of patients who underwent pars plana vitrectomy (PPV) with scleral depressed vitreous shaving, 360 degree peripheral endolaser, and 14% C3F8 gas for rhegmatogenous retinal detachment (RRD). Materials and Methods : A retrospective review of a consecutive series of patients who underwent primary repair of RRD by PPV with scleral depressed vitreous shaving, 360 degree peripheral endolaser, and 14% perfluoropropane (C 3 F 8 ) was conducted. Patients with less than 3 months follow-up, previous retinal surgery, and higher than grade B proliferative vitreoretinopathy were excluded. Results : Ninety-one eyes were included in the study. The mean age was 60.1 years. The mean follow-up was 13.7 months. The macula was detached in 63% (58/91) of the eyes. The reattachment rate after one surgical procedure was 95% (86/91) while overall reattachment rate was 100%. There was no statistically significant difference between reattachment rates of superior, nasal/temporal, or inferior RRDs. The mean final best corrected visual acuity (BCVA) was 20/40. Of all the patients, 66% of patients with macula-off RRDs had a final BCVA of 20/40 or better.
PPV with scleral depressed vitreous shaving, 360 degree peripheral endolaser, and 14% C 3 F 8 leads to successful anatomical reattachment with visual improvement in patients with primary RRD.
目的:回顾接受巩膜压迫下玻璃体切除、360度周边视网膜光凝以及14% C3F8气体治疗孔源性视网膜脱离(RRD)患者的特征及治疗结果。材料与方法:对一系列连续接受巩膜压迫下玻璃体切除、360度周边视网膜光凝以及14%全氟丙烷(C3F8)进行RRD一期修复的患者进行回顾性研究。排除随访时间不足3个月、既往有视网膜手术史以及增生性玻璃体视网膜病变分级高于B级的患者。结果:91只眼纳入研究。平均年龄60.1岁。平均随访时间13.7个月。63%(58/91)的患眼黄斑脱离。一次手术后视网膜复位率为95%(86/91),总体视网膜复位率为100%。上方、鼻侧/颞侧或下方RRD的复位率之间无统计学显著差异。最终最佳矫正视力(BCVA)平均为20/40。在所有患者中,黄斑脱离的RRD患者中有66%最终BCVA达到20/40或更好。结论:巩膜压迫下玻璃体切除、360度周边视网膜光凝以及14% C3F8可使原发性RRD患者实现成功的解剖复位并改善视力。